C57BL/6 Mice Pretreated With Alpha-Tocopherol Show a Better Outcome of Trypanosoma cruzi Infection With Less Tissue Inflammation and Fibrosis

Chagas disease is accompanied by a multisystem inflammatory disorder that follows Trypanosoma cruzi infection. Alpha-tocopherol has been described as an antioxidant and a potential adjuvant to enhance immune responses to vaccines. Therefore, we have evaluated the immune response to T. cruzi infectio...

Full description

Bibliographic Details
Main Authors: Amanda C. O. Silva, Maiara Bonfim, Jonathan L. M. Fontes, Washington L. C. dos-Santos, José Mengel, Fabíola Cardillo
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-01-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2022.833560/full
_version_ 1818332722811109376
author Amanda C. O. Silva
Maiara Bonfim
Jonathan L. M. Fontes
Washington L. C. dos-Santos
Washington L. C. dos-Santos
José Mengel
José Mengel
Fabíola Cardillo
author_facet Amanda C. O. Silva
Maiara Bonfim
Jonathan L. M. Fontes
Washington L. C. dos-Santos
Washington L. C. dos-Santos
José Mengel
José Mengel
Fabíola Cardillo
author_sort Amanda C. O. Silva
collection DOAJ
description Chagas disease is accompanied by a multisystem inflammatory disorder that follows Trypanosoma cruzi infection. Alpha-tocopherol has been described as an antioxidant and a potential adjuvant to enhance immune responses to vaccines. Therefore, we have evaluated the immune response to T. cruzi infection upon alpha-tocopherol pre-administration. The results show that administration of alpha-tocopherol before the infection results in lower parasitemia and lower mortality of C57BL/6 mice infected with the Tulahuen T. cruzi strain. Alpha-tocopherol administration in normal C57BL/6 mice resulted in higher levels of IFN-γ production by T and NK cells before and after the infection with T. cruzi. More importantly, previous administration of alpha-tocopherol increased the production of IL-10 by T and myeloid suppressor cells and the formation of effector memory T cells while decreasing the expression of PD-1 on T cells. These results suggest that alpha-tocopherol may limit the appearance of dysfunctional T cells during the acute and early chronic phases of T. cruzi infection, contributing to control infection. In addition, alpha-tocopherol could diminish tissue inflammation and fibrosis in late acute disease. These results strongly suggest that alpha-tocopherol may be a helpful agent to be considered in Chagas disease.
first_indexed 2024-12-13T13:40:16Z
format Article
id doaj.art-3a1d629733484f9ca832f6f61fd2a607
institution Directory Open Access Journal
issn 1664-3224
language English
last_indexed 2024-12-13T13:40:16Z
publishDate 2022-01-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Immunology
spelling doaj.art-3a1d629733484f9ca832f6f61fd2a6072022-12-21T23:43:36ZengFrontiers Media S.A.Frontiers in Immunology1664-32242022-01-011310.3389/fimmu.2022.833560833560C57BL/6 Mice Pretreated With Alpha-Tocopherol Show a Better Outcome of Trypanosoma cruzi Infection With Less Tissue Inflammation and FibrosisAmanda C. O. Silva0Maiara Bonfim1Jonathan L. M. Fontes2Washington L. C. dos-Santos3Washington L. C. dos-Santos4José Mengel5José Mengel6Fabíola Cardillo7Laboratory of Molecular and Structural Pathology, Gonçalo Moniz Institute, Fiocruz, Salvador, BrazilLaboratory of Molecular and Structural Pathology, Gonçalo Moniz Institute, Fiocruz, Salvador, BrazilLaboratory of Molecular and Structural Pathology, Gonçalo Moniz Institute, Fiocruz, Salvador, BrazilLaboratory of Molecular and Structural Pathology, Gonçalo Moniz Institute, Fiocruz, Salvador, BrazilDepartment of Pathology, Faculty of Medicine, Federal University of Bahia, UFBA, Salvador, BrazilOswaldo Cruz Institute, Fiocruz, Rio de Janeiro, BrazilPetrópolis Medical School, UNIFASE, Petrópolis, BrazilLaboratory of Molecular and Structural Pathology, Gonçalo Moniz Institute, Fiocruz, Salvador, BrazilChagas disease is accompanied by a multisystem inflammatory disorder that follows Trypanosoma cruzi infection. Alpha-tocopherol has been described as an antioxidant and a potential adjuvant to enhance immune responses to vaccines. Therefore, we have evaluated the immune response to T. cruzi infection upon alpha-tocopherol pre-administration. The results show that administration of alpha-tocopherol before the infection results in lower parasitemia and lower mortality of C57BL/6 mice infected with the Tulahuen T. cruzi strain. Alpha-tocopherol administration in normal C57BL/6 mice resulted in higher levels of IFN-γ production by T and NK cells before and after the infection with T. cruzi. More importantly, previous administration of alpha-tocopherol increased the production of IL-10 by T and myeloid suppressor cells and the formation of effector memory T cells while decreasing the expression of PD-1 on T cells. These results suggest that alpha-tocopherol may limit the appearance of dysfunctional T cells during the acute and early chronic phases of T. cruzi infection, contributing to control infection. In addition, alpha-tocopherol could diminish tissue inflammation and fibrosis in late acute disease. These results strongly suggest that alpha-tocopherol may be a helpful agent to be considered in Chagas disease.https://www.frontiersin.org/articles/10.3389/fimmu.2022.833560/fullChagas’ diseaseTrypanosoma cruzifibrosisimmunomodulationadjuvantsinterleukin-10
spellingShingle Amanda C. O. Silva
Maiara Bonfim
Jonathan L. M. Fontes
Washington L. C. dos-Santos
Washington L. C. dos-Santos
José Mengel
José Mengel
Fabíola Cardillo
C57BL/6 Mice Pretreated With Alpha-Tocopherol Show a Better Outcome of Trypanosoma cruzi Infection With Less Tissue Inflammation and Fibrosis
Frontiers in Immunology
Chagas’ disease
Trypanosoma cruzi
fibrosis
immunomodulation
adjuvants
interleukin-10
title C57BL/6 Mice Pretreated With Alpha-Tocopherol Show a Better Outcome of Trypanosoma cruzi Infection With Less Tissue Inflammation and Fibrosis
title_full C57BL/6 Mice Pretreated With Alpha-Tocopherol Show a Better Outcome of Trypanosoma cruzi Infection With Less Tissue Inflammation and Fibrosis
title_fullStr C57BL/6 Mice Pretreated With Alpha-Tocopherol Show a Better Outcome of Trypanosoma cruzi Infection With Less Tissue Inflammation and Fibrosis
title_full_unstemmed C57BL/6 Mice Pretreated With Alpha-Tocopherol Show a Better Outcome of Trypanosoma cruzi Infection With Less Tissue Inflammation and Fibrosis
title_short C57BL/6 Mice Pretreated With Alpha-Tocopherol Show a Better Outcome of Trypanosoma cruzi Infection With Less Tissue Inflammation and Fibrosis
title_sort c57bl 6 mice pretreated with alpha tocopherol show a better outcome of trypanosoma cruzi infection with less tissue inflammation and fibrosis
topic Chagas’ disease
Trypanosoma cruzi
fibrosis
immunomodulation
adjuvants
interleukin-10
url https://www.frontiersin.org/articles/10.3389/fimmu.2022.833560/full
work_keys_str_mv AT amandacosilva c57bl6micepretreatedwithalphatocopherolshowabetteroutcomeoftrypanosomacruziinfectionwithlesstissueinflammationandfibrosis
AT maiarabonfim c57bl6micepretreatedwithalphatocopherolshowabetteroutcomeoftrypanosomacruziinfectionwithlesstissueinflammationandfibrosis
AT jonathanlmfontes c57bl6micepretreatedwithalphatocopherolshowabetteroutcomeoftrypanosomacruziinfectionwithlesstissueinflammationandfibrosis
AT washingtonlcdossantos c57bl6micepretreatedwithalphatocopherolshowabetteroutcomeoftrypanosomacruziinfectionwithlesstissueinflammationandfibrosis
AT washingtonlcdossantos c57bl6micepretreatedwithalphatocopherolshowabetteroutcomeoftrypanosomacruziinfectionwithlesstissueinflammationandfibrosis
AT josemengel c57bl6micepretreatedwithalphatocopherolshowabetteroutcomeoftrypanosomacruziinfectionwithlesstissueinflammationandfibrosis
AT josemengel c57bl6micepretreatedwithalphatocopherolshowabetteroutcomeoftrypanosomacruziinfectionwithlesstissueinflammationandfibrosis
AT fabiolacardillo c57bl6micepretreatedwithalphatocopherolshowabetteroutcomeoftrypanosomacruziinfectionwithlesstissueinflammationandfibrosis